News | March 14, 2023
Alpla and Inden pharma form joint venture
ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma
ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
Company will invest in capacity increases, technological capabilities and long-term partnerships with key pharmaceutical and biotech companies
The inspection concluded with no observations
Time to combine innovation, access and technology to deliver positive patient outcomes
Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.
The agreement is for USFDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
The Development Center with its state-of-the art laboratories and flexible pilot capacities is set to become Siegfried's global research and development hub for its Drug Products sites, strengthening the global network
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Subscribe To Our Newsletter & Stay Updated
